Literature DB >> 15321928

Phosphorylation regulates Id3 function in vascular smooth muscle cells.

Scott T Forrest1, Angela M Taylor, Ian J Sarembock, Demetra Perlegas, Coleen A McNamara.   

Abstract

Understanding the mechanisms that regulate cell cycle progression in vascular smooth muscle cells (VSMCs) is key to understanding and modulating vascular lesion formation. Results of the present study provide the first evidence that phosphorylation of the helix-loop-helix factor Id3 in VSMCs occurs in vitro and in vivo and provides a regulatory switch controlling Id3-induced regulation of p21Cip1 and VSMC growth.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15321928      PMCID： PMC2929385          DOI： 10.1161/01.RES.0000142735.67542.5a

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


  13 in total

Review 1.  CDK inhibitors: positive and negative regulators of G1-phase progression.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1999-06-15       Impact factor: 11.361

2.  Prevention of graft coronary arteriosclerosis by antisense cdk2 kinase oligonucleotide.

Authors:  J Suzuki; M Isobe; R Morishita; M Aoki; S Horie; Y Okubo; Y Kaneda; Y Sawa; H Matsuda; T Ogihara; M Sekiguchi
Journal:  Nat Med       Date:  1997-08       Impact factor: 53.440

3.  Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins.

Authors:  S Prabhu; A Ignatova; S T Park; X H Sun
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

4.  Regulation of Id3 cell cycle function by Cdk-2-dependent phosphorylation.

Authors:  R W Deed; E Hara; G T Atherton; G Peters; J D Norton
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

5.  Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.

Authors:  F C Tanner; M Boehm; L M Akyürek; H San; Z Y Yang; J Tashiro; G J Nabel; E G Nabel
Journal:  Circulation       Date:  2000-05-02       Impact factor: 29.690

6.  Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial.

Authors:  M J Mann; A D Whittemore; M C Donaldson; M Belkin; M S Conte; J F Polak; E J Orav; A Ehsan; G Dell'Acqua; V J Dzau
Journal:  Lancet       Date:  1999-10-30       Impact factor: 79.321

7.  Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury.

Authors:  Z Y Yang; R D Simari; N D Perkins; H San; D Gordon; G J Nabel; E G Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

8.  Vascular injury induces posttranscriptional regulation of the Id3 gene: cloning of a novel Id3 isoform expressed during vascular lesion formation in rat and human atherosclerosis.

Authors:  M E Matsumura; F Li; L Berthoux; B Wei; D R Lobe; C Jeon; M L Hammarskjöld; C A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-05       Impact factor: 8.311

9.  Identification of a novel redox-sensitive gene, Id3, which mediates angiotensin II-induced cell growth.

Authors:  Cornelius Mueller; Stephanie Baudler; Hilke Welzel; Michael Böhm; Georg Nickenig
Journal:  Circulation       Date:  2002-05-21       Impact factor: 29.690

10.  CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferation.

Authors:  E E Brooks; N S Gray; A Joly; S S Kerwar; R Lum; R L Mackman; T C Norman; J Rosete; M Rowe; S R Schow; P G Schultz; X Wang; M M Wick; D Shiffman
Journal:  J Biol Chem       Date:  1997-11-14       Impact factor: 5.157
View more
  13 in total

1.  Microvascular lesions by estrogen-induced ID3: its implications in cerebral and cardiorenal vascular disease.

Authors:  Jayanta K Das; Quentin Felty
Journal:  J Mol Neurosci       Date:  2014-08-17       Impact factor: 3.444

2.  Id3 is a novel atheroprotective factor containing a functionally significant single-nucleotide polymorphism associated with intima-media thickness in humans.

Authors:  Amanda C Doran; Allison B Lehtinen; Nahum Meller; Michael J Lipinski; R Parker Slayton; Stephanie N Oldham; Marcus D Skaflen; Joseph Yeboah; Stephen S Rich; Donald W Bowden; Coleen A McNamara
Journal:  Circ Res       Date:  2010-02-25       Impact factor: 17.367

3.  Inefficient skeletal muscle repair in inhibitor of differentiation knockout mice suggests a crucial role for BMP signaling during adult muscle regeneration.

Authors:  Jared L Clever; Yuki Sakai; Rong A Wang; Darren B Schneider
Journal:  Am J Physiol Cell Physiol       Date:  2010-02-24       Impact factor: 4.249

4.  Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness.

Authors:  Jun Hong; Jian Zhou; Junjiang Fu; Tao He; Jun Qin; Li Wang; Lan Liao; Jianming Xu
Journal:  Cancer Res       Date:  2011-04-18       Impact factor: 12.701

Review 5.  Molecular basis of the association between transcription regulators nuclear respiratory factor 1 and inhibitor of DNA binding protein 3 and the development of microvascular lesions.

Authors:  Christian Michael Perez; Quentin Felty
Journal:  Microvasc Res       Date:  2022-02-07       Impact factor: 3.514

6.  Loss of Id3 (Inhibitor of Differentiation 3) Increases the Number of IgM-Producing B-1b Cells in Ischemic Skeletal Muscle Impairing Blood Flow Recovery During Hindlimb Ischemia.

Authors:  Victoria Osinski; Prasad Srikakulapu; Young Min Haider; Melissa A Marshall; Vijay C Ganta; Brian H Annex; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-11-23       Impact factor: 8.311

7.  Angiotensin II induces a region-specific hyperplasia of the ascending aorta through regulation of inhibitor of differentiation 3.

Authors:  A Phillip Owens; Venkateswaran Subramanian; Jessica J Moorleghen; Zhenheng Guo; Coleen A McNamara; Lisa A Cassis; Alan Daugherty
Journal:  Circ Res       Date:  2009-12-17       Impact factor: 17.367

8.  The helix-loop-helix factors Id3 and E47 are novel regulators of adiponectin.

Authors:  Amanda C Doran; Nahum Meller; Alexis Cutchins; Hamid Deliri; R Parker Slayton; Stephanie N Oldham; Jae B Kim; Susanna R Keller; Coleen A McNamara
Journal:  Circ Res       Date:  2008-07-31       Impact factor: 17.367

9.  Increased 12/15-lipoxygenase enhances cell growth, fibronectin deposition, and neointimal formation in response to carotid injury.

Authors:  Hamid Deliri; Nahum Meller; Ajay Kadakkal; Rohit Malhotra; Jordan Brewster; Amanda C Doran; Hong Pei; Stephanie N Oldham; Marcus D Skaflen; James C Garmey; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-10-14       Impact factor: 10.514

10.  Genome-wide changes accompanying knockdown of fatty acid synthase in breast cancer.

Authors:  Lynn M Knowles; Jeffrey W Smith
Journal:  BMC Genomics       Date:  2007-06-12       Impact factor: 3.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.